Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
US Department of Justice
Covington
Queensland Health
Farmers Insurance
Healthtrust
US Army
Express Scripts
AstraZeneca
Chinese Patent Office

Generated: January 20, 2018

DrugPatentWatch Database Preview

PROVENTIL Drug Profile

« Back to Dashboard

When do Proventil patents expire, and when can generic versions of Proventil launch?

Proventil is a drug marketed by Schering and 3m Drug Delivery and is included in six NDAs. There is one patent protecting this drug and one Paragraph IV challenge.

The generic ingredient in PROVENTIL is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.

US Patents and Regulatory Information for PROVENTIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering PROVENTIL albuterol AEROSOL, METERED;INHALATION 017559-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Schering PROVENTIL albuterol sulfate TABLET;ORAL 017853-002 May 7, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Schering PROVENTIL albuterol sulfate SYRUP;ORAL 018062-001 Jan 19, 1983 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
3m Drug Delivery PROVENTIL-HFA albuterol sulfate AEROSOL, METERED;INHALATION 020503-001 Aug 15, 1996 BX RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Schering PROVENTIL albuterol sulfate SOLUTION;INHALATION 019243-002 Jan 14, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Schering PROVENTIL albuterol sulfate SOLUTION;INHALATION 019243-001 Jan 14, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Schering PROVENTIL albuterol sulfate TABLET;ORAL 017853-001 May 7, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Schering PROVENTIL albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 019383-001 Jul 13, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for PROVENTIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering PROVENTIL albuterol sulfate SOLUTION;INHALATION 019243-001 Jan 14, 1987 ➤ Subscribe ➤ Subscribe
Schering PROVENTIL albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 019383-001 Jul 13, 1987 ➤ Subscribe ➤ Subscribe
Schering PROVENTIL albuterol AEROSOL, METERED;INHALATION 017559-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Schering PROVENTIL albuterol sulfate SYRUP;ORAL 018062-001 Jan 19, 1983 ➤ Subscribe ➤ Subscribe
Schering PROVENTIL albuterol sulfate TABLET;ORAL 017853-002 May 7, 1982 ➤ Subscribe ➤ Subscribe
Schering PROVENTIL albuterol sulfate TABLET;ORAL 017853-002 May 7, 1982 ➤ Subscribe ➤ Subscribe
Schering PROVENTIL albuterol sulfate TABLET;ORAL 017853-001 May 7, 1982 ➤ Subscribe ➤ Subscribe
Schering PROVENTIL albuterol sulfate TABLET;ORAL 017853-001 May 7, 1982 ➤ Subscribe ➤ Subscribe
Schering PROVENTIL albuterol AEROSOL, METERED;INHALATION 017559-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Schering PROVENTIL albuterol sulfate SOLUTION;INHALATION 019243-001 Jan 14, 1987 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for PROVENTIL
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Inhalation Aerosol 0.09 mg base per actuation ➤ Subscribe 5/20/2015

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Express Scripts
Chubb
Covington
UBS
Fuji
Medtronic
US Department of Justice
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot